[Alphacalcidol combined with dexamethasone for reducing pulmonary fibrosis in mice and its mechanism].

Yang, Xiaoyu; Wu, Ling; Li, Guoping; Ran, Qin; Zhang, Lei

Yang, Xiaoyu; Wu, Ling; Li, Guoping; Ran, Qin; Zhang, Lei.

Afiliação

Yang X; Department of Respiratory Diseases, Southwest Medical University, Luzhou 646000, China.
Wu L; Department of Respiratory Diseases, West China School of Clinical Medicine, Sichuan University, Chengdu 610000, China.
Li G; Department of Respiratory Diseases, Southwest Medical University, Luzhou 646000, China. *Corresponding author, E-mail: lzlgp@163.com.
Ran Q; Department of Respiratory Diseases, Southwest Medical University, Luzhou 646000, China.
Zhang L; Department of Respiratory Diseases, Southwest Medical University, Luzhou 646000, China.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi ; 33(4): 488-491, 2017 Apr.

Article em Zh | MEDLINE | ID: mdl-28395719

Assuntos

Dexametasona/administração & dosagem; Hidroxicolecalciferóis/administração & dosagem; Fibrose Pulmonar/tratamento farmacológico; Animais; Modelos Animais de Doenças; Quimioterapia Combinada; Humanos; Interleucina-6/genética; Interleucina-6/metabolismo; Masculino; Camundongos; Camundongos Endogâmicos C57BL; Fibrose Pulmonar/genética; Fibrose Pulmonar/metabolismo; Fator de Crescimento Transformador beta1/genética; Fator de Crescimento Transformador beta1/metabolismo; Fator de Necrose Tumoral alfa/genética; Fator de Necrose Tumoral alfa/metabolismo

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar / Dexametasona / Hidroxicolecalciferóis Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: Zh Revista: Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi Ano de publicação: 2017 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links